Insiders Cardiff Oncology, Inc.

Equities

CRDF

US14147L1089

Real-time Estimate Cboe BZX Other stock markets 02:55:30 2024-05-08 pm EDT			5-day change	1st Jan Change
3.315 ^USD	+0.15%		-21.28%	+125.00%

May. 02	Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024
May. 02	Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cardiff Oncology Appoints Fairooz Kabbinavar as Chief Medical Officer	23-02-02	CI
Insider Buy: Cardiff Oncology	22-09-19	MT
Cardiff Oncology Chief Medical Officer Katherine Ruffner to Depart	22-04-12	MT
Cardiff Oncology, Inc. Announces Executive Changes	22-04-12	CI
Cardiff Oncology, Inc Announces Executive Appointments	22-01-11	CI
Insider Buy: Cardiff Oncology	21-09-13	MT
Cardiff Oncology Announces Appointment of James E. Levine as Chief Financial Officer	21-07-12	CI
Cardiff Oncology Announces Appointment of Katherine L. Ruffner, M.D., as Chief Medical Officer	21-07-12	CI
Cardiff Oncology, Inc. Announces Board Changes	21-06-10	CI
Insider Trends: Insider Purchase Continues Cardiff Oncology Positive Trend	21-03-24	MT
Cardiff Oncology, Inc. Announces Executive Changes	20-12-21	CI
Cardiff Oncology, Inc. Appoints Mark Erlander as Director	20-06-19	CI
TrovaGene, Inc. will Change its Name to Cardiff Oncology, Inc	20-05-07	CI
Trovagene, Inc. Announces Executive Changes	20-05-06	CI
TrovaGene, Inc. Expands Board with Addition of Three Industry Leaders	20-04-22	CI
Trovagene Inc. Announces Resignation of Athena Countouriotis as a Director	20-01-30	CI
Trovagene, Inc. Announces Resignation of Dr. Stanley Tennant as Director, Effective December 31, 2018	18-12-14	CI
Trovagene Receives USAN Approval for “Onvansertib” as Nonproprietary Name for First-in-Class, 3rd Generation PLK1 Inhibitor Drug Candidate, PCM-075	18-08-15	CI
Trovagene Announces Executive Changes	18-06-22	CI
Trovagene, Inc. Appoints Athena Countouriotis to the Board of Directors	17-09-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cardiff Oncology, Inc.

Equities

CRDF

US14147L1089

Insiders

Filters